Products for Research Use Only
RegisterLogin

Aclacinomycin A

CAT: 0804-HY-N2306-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N2306-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Aclacinomycin A (Aclarubicin) is an orally active and potent anthracycline antitumor antibiotic. Aclacinomycin A is an inhibitor of topoisomerase I and II. Aclacinomycin A inhibits synthesis of nucleic acid, especially RNA. Aclacinomycin A might inhibit the 26S protease complex as well as the ubiquitin-ATP-dependent proteolysis[1][2][3].
CAS Number
57576-44-0
Product Name Alternative
Aclarubicin
UNSPSC
12171500
Hazard Statement
H301
Target
Antibiotic; DNA/RNA Synthesis; Proteasome; Topoisomerase
Type
Dye Reagents
Related Pathways
Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/aclacinomycin-a.html
Purity
99.03
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C([C@@H]1C2=CC(C(C3=CC=CC(O)=C43)=O)=C(C4=O)C(O)=C2[C@@H](O[C@@](O[C@@H](C)[C@H]5O[C@@](O[C@@H](C)[C@H]6O[C@](CCC7=O)([H])O[C@H]7C)([H])C[C@@H]6O)([H])C[C@@H]5N(C)C)C[C@]1(O)CC)OC
Molecular Formula
C42H53NO15
Molecular Weight
811.87
Precautions
H301
References & Citations
[1]Isoe T, et al. Inhibition of different steps of the ubiquitin system by CDDP and aclarubicin. Biochim Biophys Acta. 1992 Sep 15;1117 (2) :131-5.|[2]Hajji N, et al. Induction of genotoxic and cytotoxic damage by aclarubicin, a dual topoisomerase inhibitor. Mutat Res. 2005 May 2;583 (1) :26-35.|[3]Iihoshi H, et al. Aclarubicin, an anthracycline anti-cancer drug, fluorescently contrasts mitochondria and reduces the oxygen consumption rate in living human cells. Toxicol Lett. 2017 Aug 5;277:109-114. |[4]Hori S, Shirai M, Hirano S, Oki T, Inui T, Tsukagoshi S, Ishizuka M, Takeuchi T, Umezawa H. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity. Gan. 1977 Oct;68 (5) :685-90.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Dye Reagents
Clinical Information
Launched
Isoform
Topo I; Topo II
Citation 01
Biomolecules. 2025 Jul 6.|Patent. US20250129329A1.|Bioengineered. 2022 Feb;13 (2) :2207-2216.|bioRxiv. 2023 Jan 13.|Int J Hyperthermia. 2022;39 (1) :998-1009.

Alternative Products

CatalogName
BUP21866Aclacinomycin A
MBS5773382Aclacinomycin
A14910-10Aclacinomycin A 10mg
C04659Aclacinomycin A hydrochloride
257194-01Aclacinomycin HCl
440910-01Aclarubicin (Aclacinomycin A)
abx283139-01Aclacinomycin A HCl
A14910-5Aclacinomycin A 5mg
A14910-1Aclacinomycin A 1mg
A14910-50Aclacinomycin A 50mg

Popular Products